Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Photoswitchable Diazocine Derivative for Adenosine A3 Receptor Activation in Psoriasis

  • López Cano, Marc|||0000-0001-8885-3726
  • Scortichini, Mirko
  • Tosh, Dilip K.
  • Salmaso, Veronica
  • Ko, Tongil|||0000-0002-3070-9243
  • Salort, Glòria
  • Filgaira, Ingrid|||0000-0002-9886-3925
  • Soler, Concepció|||0000-0001-6502-5012
  • Trauner, Dirk|||0000-0002-6782-6056
  • Hernando, Jordi|||0000-0002-1126-4138
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Ciruela, Francisco|||0000-0003-0832-3739
Incorporating photoisomerizable moieties within drugs offers the possibility of rapid and reversible light-dependent switching between active and inactive configurations. Here, we developed a photoswitchable adenosine A3 receptor (A3R) agonist that confers optical control on this G protein-coupled receptor through noninvasive topical skin irradiation in an animal model of psoriasis. This was achieved by covalently bonding an adenosine-5'-methyluronamide moiety to a diazocine photochrome, whose singular photoswitching properties facilitated repeated interconversion between a thermally stable, biologically inactive Z agonist form and a photoinduced, pharmacologically active E configuration. As a result, our photoswitchable agonist allowed the precise modulation of A3R function both in vitro and in vivo, which led to a clear light-controlled pharmacotherapeutic effect on mouse skin lesions. This breakthrough not only demonstrates the potential of diazocine photoswitches for in vivo photopharmacology but also paves the way for the development of new strategies for skin-related diseases that require localized and temporally controlled drug action.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Error monitoring and correction in violin performance: an EEG study

  • Blanco, Angel David
  • Costa-Faidella, Jordi
  • Pérez Carrillo, Alfonso Antonio, 1977-
  • Dalmazzo, David
  • Ramirez Melendez, Rafael
  • San Miguel Insúa, Iria
Previous research using electroencephalography (EEG) has investigated neural error-related music production processes in expert pianists reporting a frontal event-related negativity followed by a P300 event-related potential (ERP) after mistuned notes. However, piano playing does not rely on auditory feedback and corrective movements when dealing with accurate note tuning, thus offering an incomplete picture about error monitoring processes in players of many other musical instruments, including the human voice. We here designed a setup allowing us to collect the EEG of expert bow-string players while performing short melodies on the violin, (a fretless instrument) while also manipulating in real-time the produced pitch in a controlled manner. 15 expert bow-string players were asked to 1) listen to a reference melody of four notes; 2) play that melody with a violin (Active Condition); and 3) listen passively to the replay of their performance (Replayed Condition). Randomly, the auditory feedback of one of the four melody notes was manipulated in the Active Condition by lowering or lifting the pitch by half semitone. We found that mistuned notes, independently of whether they were manipulated externally or were produced by natural playing errors, elicited an f-ERN followed by a P300. We also found that the amplitude of the f-ERN was larger for faster corrective movements than for slower ones. In addition, between the f-ERN and the P300, we also identified two negative components-one in parietal areas and another in central-right regions-whose amplitudes were greater for slower corrective movements. We suggest the existence of two error-monitoring systems: a "fast" system mediated by the medial frontal cortex that quickly corrects errors when certainty is high and a "slow" system mediated by the posterior parietal cortex that accumulates evidence under uncertainty before triggering correction., This work was partly sponsored by the Musical AI project (PID2019-111403GB-I00) funded by MCIN/AEI/ 10.13039/501100011033 and by 'ERDF A way of making Europe'; by the Project PID2021-128790NB-I00, funded by MCIN/AEI/ 10.13039/501100011033 / FEDER UE; and by the European Union Horizon 2020 research and innovation program under grant agreement No. 688269 (TELMI project). It has been additionally supported by the Excellence Research Group 2017SGR-974 funded by the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya and by the MDM-2017-0729-18-2M Maria de Maeztu Center of Excellence UBNeuro, funded by MCIN/AEI/ 10.13039/501100011033. ISM was supported by grant RYC-2013-12577, funded by MCIN/AEI/ 10.13039/501100011033 and by 'ESF Investing in your future'. Open access publication fees were partly covered by the University of Barcelona (Ajudes de la Universitat de Barcelona per a publicar en accés obert).
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus

  • Juárez-Flores, Diana-Luz
  • Ezquerra, Mario
  • González-Casacuberta, Ingrid
  • Ormazabal, Aida
  • Morén, Constanza
  • Tolosa, Eduardo
  • Fucho, Raquel
  • Guitart-Mampel, Mariona
  • Casado, Mercedes
  • Valldeoriola, Francesc
  • Torre-Lara, Joan de la
  • Muñoz, Esteban
  • Tobías Rossell, Ester
  • Compta, Yaroslau
  • García-García, Francesc Josep
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Martí, María-José
  • Grau-Junyent, Josep María
  • Cardellach, Francesc
  • Artuch, Rafael
  • Fernández-Santiago, Rubén
  • Garrabou, Glòria
Idiopathic Parkinson’s disease (iPD) and type 2 diabetes mellitus (T2DM) are chronic, multisystemic, and degenerative diseases associated with aging, with eventual epidemiological co-morbidity and overlap in molecular basis. This study aims to explore if metabolic and mitochondrial alterations underlie the previously reported epidemiologic and clinical co-morbidity from a molecular level. To evaluate the adaptation of iPD to a simulated pre-diabetogenic state, we exposed primary cultured fibroblasts from iPD patients and controls to standard (5 mM) and high (25 mM) glucose concentrations to further characterize metabolic and mitochondrial resilience. iPD fibroblasts showed increased organic and amino acid levels related to mitochondrial metabolism with respect to controls, and these differences were enhanced in high glucose conditions (citric, suberic, and sebacic acids levels increased, as well as alanine, glutamate, aspartate, arginine, and ornithine amino acids; p-values between 0.001 and 0.05). The accumulation of metabolites in iPD fibroblasts was associated with (and probably due to) the concomitant mitochondrial dysfunction observed at enzymatic, oxidative, respiratory, and morphologic level. Metabolic and mitochondrial plasticity of controls was not observed in iPD fibroblasts, which were unable to adapt to different glucose conditions. Impaired metabolism and mitochondrial activity in iPD may limit energy supply for cell survival. Moreover, reduced capacity to adapt to disrupted glucose balance characteristic of T2DM may underlay the co-morbidity between both diseases. Conclusions: Fibroblasts from iPD patients showed mitochondrial impairment, resulting in the accumulation of organic and amino acids related to mitochondrial metabolism, especially when exposed to high glucose. Mitochondrial and metabolic defects down warding cell plasticity to adapt to changing glucose bioavailability may explain the comorbidity between iPD and T2DM., This work was supported by funds from the Integrated Projects of Excellence PIE14/00061 and the Fondo de Investigaciones Sanitarias of the Instituto de Salud Carlos III (ISCIII) (grant numbers PI1800498 and PI1800451), the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), all initiatives of ISCIII and FEDER (‘Una manera de hacer Europa’), as well as Fundació Privada Cellex and Suports a Grups de Recerca (grant code 2017 SGR 893) and CERCA programs from the Generalitat de Catalunya. Maria de Maeztu Unit of Excellence funded our institution (Institute of Neurosciences, University of Barcelona) as consolidated excellence centre (MDM-2017-0729, Ministry of Science, Innovation and Universities). Two grants from the Spanish government allowed facility maintenance (SAF2017-85877-R from CGR and both SAF2015-69944-R and PID2019-111669RB-I00 from JCFC), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease

  • Fernández-García, Sara
  • Conde-Berriozabal, Sara
  • García-García, Esther
  • Gort-Paniello, Clara
  • Bernal-Casas, David
  • García-Díaz Barriga, Gerardo
  • López-Gil, Xavier
  • Muñoz-Moreno, Emma
  • Soria, Guadalupe
  • Campa, Leticia
  • Artigas, Francesc
  • Rodríguez, Manuel José
  • Alberch, Jordi
  • Masana, Mercè
Huntington's disease (HD) is a neurological disorder characterized by motor disturbances. HD pathology is most prominent in the striatum, the central hub of the basal ganglia. The cerebral cortex is the main striatal afferent, and progressive cortico-striatal disconnection characterizes HD. We mapped striatal network dysfunction in HD mice to ultimately modulate the activity of a specific cortico-striatal circuit to ameliorate motor symptoms and recover synaptic plasticity. Multimodal MRI in vivo indicates cortico-striatal and thalamo-striatal functional network deficits and reduced glutamate/glutamine ratio in the striatum of HD mice. Moreover, optogenetically-induced glutamate release from M2 cortex terminals in the dorsolateral striatum (DLS) was undetectable in HD mice and striatal neurons show blunted electrophysiological responses. Remarkably, repeated M2-DLS optogenetic stimulation normalized motor behavior in HD mice and evoked a sustained increase of synaptic plasticity. Overall, these results reveal that selective stimulation of the M2-DLS pathway can become an effective therapeutic strategy in HD., We are very grateful to Ana Lopez (María de Maeztu Unit of Excellence, Institute of Neurosciences, University of Barcelona, MDM-2017–0729, Ministry of Science, Innovation, and Universities) and Maite Muñoz for their excellent technical support. This work has been funded by the Spanish Ministry of Sciences, Innovation and Universities through projects no. SAF2017-88076-R, RETICS de Terapia Celular, Instituto de Salud Carlos III (RD06/0010/0006), and la Marato´ de TV3. This research is part of NEUROPA. The NEUROPA Project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 863214.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function

  • Santos-Gómez, Ana
  • Miguez-Cabello, Federico
  • García-Recio, Adrián
  • Locubiche-Serra, Sílvia
  • García-Díaz, Roberto
  • Soto-Insuga, Víctor
  • Guerrero-López, Rosa
  • Juliá-Palacios, Natalia
  • Ciruela, Francisco
  • García-Cazorla, Angels
  • Soto, David
  • Olivella, Mireia
  • Altafaj, Xavier
De novo GRIN variants, encoding for the ionotropic glutamate NMDA receptor subunits, have been recently associated with GRIN-related disorders, a group of rare paediatric encephalopathies. Current investigational and clinical efforts are focused to functionally stratify GRIN variants, towards precision therapies of this primary disturbance of glutamatergic transmission that affects neuronal function and brain. In the present study, we aimed to comprehensively delineate the functional outcomes and clinical phenotypes of GRIN protein truncating variants (PTVs)—accounting for ~20% of disease-associated GRIN variants—hypothetically provoking NMDAR hypofunctionality. To tackle this question, we created a comprehensive GRIN PTVs variants database compiling a cohort of nine individuals harbouring GRIN PTVs, together with previously identified variants, to build-up an extensive GRIN PTVs repertoire composed of 293 unique variants. Genotype–phenotype correlation studies were conducted, followed by cell-based assays of selected paradigmatic GRIN PTVs and their functional annotation. Genetic and clinical phenotypes meta-analysis revealed that heterozygous GRIN1, GRIN2C, GRIN2D, GRIN3A and GRIN3B PTVs are non-pathogenic. In contrast, heterozygous GRIN2A and GRIN2B PTVs are associated with specific neurological clinical phenotypes in a subunit- and domain-dependent manner. Mechanistically, cell-based assays showed that paradigmatic pathogenic GRIN2A and GRIN2B PTVs result on a decrease of NMDAR surface expression and NMDAR-mediated currents, ultimately leading to NMDAR functional haploinsufficiency. Overall, these findings contribute to delineate GRIN PTVs genotype–phenotype association and GRIN variants stratification. Functional studies showed that GRIN2A and GRIN2B pathogenic PTVs trigger NMDAR hypofunctionality, and thus accelerate therapeutic decisions for this neurodevelopmental condition., ISCIII, cofunded by European Regional Development Fund (ERDF), a way to build Europe (grants PI19/00348 and PI16/00851); Miguel Servet Program (CPII16/00021, ISCIII) and Serra Húnter Fellow to X.A.; SAF2016-77830-R to M.O.; European Regional development Fund (ERDF)-Ministerio de Ciencia e Innovación (grant BFU2017-83317-P) and Ministerio de Ciencia e Innovación-María de Maeztu (MDM-2017-0729) to D.S. and PI18/00111 [ISCIII, cofunded by European Regional Development Fund (ERDF), a way to build Europe] to À.G.-C. and N.J.-P.; Fundación Tatiana Pérez de Guzmán el Bueno PhD fellowship to A.S.-G.; crowdfunding initiative Precipita (FECYT) to F.M.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Modulation of pain and itch sensitivity by TRESK background K+ channel

  • Andrés-Bilbé, Alba
  • Castellanos, Aida
  • Pujol, Anna
  • Comes, Núria
  • Callejo, Gerard
  • Gasull, Xavier
Resumen del trabajo presentado al International Workshop on Chronic Pain and Itch: Mechanisms and Circuits, celebrado en Alicante (España) del 20 al 22 de octubre de 2021., Supported by European Union, Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Ciencia e Innovación and Instituto de Salud Carlos III FIS PI1700296, RETIC RD16/0008/0014 and Maria de Maeztu MDM-2017-0729. Generalitat de Catalunya: 2017SGR737. European Union H2020-MSCA-ITN-2016 Pain-Net Network., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders

  • Ramírez, Sara
  • Haddad-Tóvolli, Roberta
  • Radosevic, Marija
  • Toledo, Miriam
  • Pané, Adriana
  • Alcolea, Daniel
  • Ribas, Vicent
  • Milà-Guasch, Maria
  • Pozo, Macarena
  • Obri, Arnaud
  • Eyre, Elena
  • Gómez-Valadés, Alicia
  • Chivite, Iñigo
  • Eeckhout, Tomas van
  • Zalachoras, Ioannis
Obesity and type 2 diabetes are associated with cognitive dysfunction. Because the hypothalamus is implicated in energy balance control and memory disorders, we hypothesized that specific neurons in this brain region are at the interface of metabolism and cognition. Acute obesogenic diet administration in mice impaired recognition memory due to defective production of the neurosteroid precursor pregnenolone in the hypothalamus. Genetic interference with pregnenolone synthesis by Star deletion in hypothalamic POMC, but not AgRP neurons, deteriorated recognition memory independently of metabolic disturbances. Our data suggest that pregnenolone’s effects on cognitive function were mediated via an autocrine mechanism on POMC neurons, influencing hippocampal long-term potentiation. The relevance of central pregnenolone on cognition was also confirmed in metabolically unhealthy patients with obesity. Our data reveal an unsuspected role for POMC neuron-derived neurosteroids in cognition. These results provide the basis for a framework to investigate new facets of POMC neuron biology with implications for cognitive disorders., This work was supported by the Swiss National Science Foundation (no.176206; NCCR Synapsy grant no.185897) to C.S.; the European Research Council (ERC) advanced grant SYNEME to J.C.B.; Instituto de Salud Carlos III (ISCIII)—Fondo Europeo de Desarrollo Regional (FEDER) (PI17/00296), RETICs Oftared (RD16/0008/0014), and Generalitat de Catalunya (2017SGR737) to X.G.; Ministerio de Ciencia e Innovación (BFU2017-83317-P) to D.S.; Ministerio de Economia, Industria y Competitividad, Maria de Maeztu (MDM-2017-0729) to Institut de Neurociencies, Universitat de Barcelona; ISCIII-FEDER (PI14/01126, PI17/01019), the National Institutes of Health (NIA grants 1R01AG056850-01A1, R21AG056974, and R01AG061566), Fundació La Marató de TV3 (20141210), and Generalitat de Catalunya (SLT006/17/00119) to J.F.; ISCIII-FEDER (PI17/00279 and PI20/0042), Fundació La Marató de TV3 (201614.31), and Generalitat de Catalunya (SLT008/18/00127) to A.J.; Plan Nacional de I+D funded by the Agencia Estatal de Investigación (AEI) and FEDER (PID2019-111669RB-I00 and PID2020-115055RB-I00), CIBEREHD, the center grant P50AA011999 Southern California Research Center for ALPD and Cirrhosis funded by NIAAA/NIH, Generalitat de Catalunya (SGR-2017-1112), the European Cooperation in Science & Technology (COST) ACTION CA17112, FUNDACIÓN BBVA (“ER stress-mitochondrial cholesterol axis in obesity-associated insulin resistance and comorbidities”), and Red Nacional 2018-102799-T de Enfermedades Metabólicas y Cáncer and Fundació La Marató de TV3 (201916/31) to J.C.F.-C.; and ERC consolidator grant MITOSENSING (725004), ISCIII-FEDER (PI16/00963), “la Caixa” Foundation (ID100010434) under agreement LCF/PR/HR19/52160016, and CERCA Programme/Generalitat de Catalunya to M.C. D.A. is supported by ISCIII (INT19/00016) and Generalitat de Catalunya PERIS program (SLT006/17/125), A.P. is supported by Hospital Clínic de Barcelona (“Ajut Josep Font”), A.O. is supported by a Miguel Servet contract (CP19/00083) from ISCIII-FEDER, and R.H.-T. is supported by a Marie Skłodowska-Curie Action fellowship (H2020-MSCA-IF) and NEUROPREG (891247). S.R. is a recipient of Juan de la Cierva Formación (FJCI-2016-28911) and Incorporación (IJC2018-037341-I) programs from the Spanish Ministry of Science and Innovation. This work was carried out in part at Esther Koplowitz Centre., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics

  • Griñán-Ferré, Christian
  • Jarné-Ferrer, Júlia
  • Bellver-Sanchís, Aina
  • Codony, Sandra
  • Puigoriol-Illamola, Dolors
  • Sanfeliu, Coral
  • Oh, Yumin
  • Lee, Seulki
  • Vázquez, Santiago
  • Pallàs, Mercè
Neuroinflammation is widely recognized as a significant hallmark of Alzheimer's disease (AD). To combat neuroinflammation, the inhibition of the soluble epoxide hydrolase (sEH) enzyme has been demonstrated crucial. Importantly, sEH inhibition could be related to other neuroprotective pathways described in AD., This work was supported by Spanish Ministerio de Ciencia e Innovación (PID2019-106285/AEI/10.13039/501100011033; PDC2021-121096/AEI/10.13039/501100011033; María de Maeztu Unit of Excellence to Institute of Neurosciences, University of Barcelona, MDM-2017-0729) and 2021SGR357 (AGAUR, Catalonia). ABS acknowledges a FI SDUR (2021 FI-B0812) fellowship to AGAUR Catalonia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Wireless, battery-free, remote photoactivation of caged-morphine for photopharmacological pain modulation without side effects

  • Kim, Minsung
  • López-Cano, Marc
  • Zhang, Kaiqing
  • Wang, Yue
  • Gómez-Santacana, Xavier
  • Flores, África
  • Wu, Mingzheng
  • Li, Shupeng
  • Zhang, Haohui
  • Wei, Yuanting
  • Li, Xiuyuan
  • Good, Cameron H.
  • Banks, Anthony R.
  • Llebaria, Amadeu
  • Hernando, Jordi
  • Sunwoo, Sung-Hyuk
  • Gu, Jianyu
  • Huang, Yonggang
  • Ciruela, Francisco
  • Rogers, John A.
Data will be made available on request., Chronic pain severely impairs physical, psychological, and cognitive functions. While opioid-based therapies can be effective, they are limited by tolerance, dependence, and adverse side effects, highlighting the need for safer alternatives. Recent advances in photopharmacology allow precise modulation of pain-related neuronal circuits, offering improved control and effectiveness. For delivery of light, fully implantable, wireless, battery-free optical systems in miniaturized forms offer attractive options relative to alternatives that use conventional bulk hardware and fiber optic tethers. This work presents a technology of this type, based on microscale light-emitting diodes (μ-ILEDs) and near-field communication (NFC) protocols, and optimized to activate photocaged morphine (pc-Mor) in targeted regions of the spinal cord. The unique flexible, lightweight designs ensure stable, minimally invasive operation in small animal model behavioral studies, with efficient power consumption and minimized thermal load on fragile tissues. Experimental results demonstrate effective pain suppression and reduced opioid-related side effects in an animal model of pain, thereby establishing this platform as a promising solution for chronic pain management., This work was funded by the Querrey-Simpson Institute for Bioelectronics. This work was also supported by FEDER/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación (PID2023-147425OB-I00 to FC, PID2020-120499RB-I00 to AL) and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) - Generalitat de Catalunya (projects 2021 SGR 00698 to FC, 2021 SGR 00064 to JH, 2021 SGR 00508 to AL)., We thank Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya for IDIBELL institutional support and Maria de Maeztu MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Error monitoring and correction in violin performance: an EEG study

  • Blanco, Angel David
  • Costa-Faidella, Jordi
  • Pérez Carrillo, Alfonso Antonio, 1977-
  • Dalmazzo, David
  • Ramirez Melendez, Rafael
  • San Miguel Insúa, Iria
Previous research using electroencephalography (EEG) has investigated neural error-related music production processes in expert pianists reporting a frontal event-related negativity followed by a P300 event-related potential (ERP) after mistuned notes. However, piano playing does not rely on auditory feedback and corrective movements when dealing with accurate note tuning, thus offering an incomplete picture about error monitoring processes in players of many other musical instruments, including the human voice. We here designed a setup allowing us to collect the EEG of expert bow-string players while performing short melodies on the violin, (a fretless instrument) while also manipulating in real-time the produced pitch in a controlled manner. 15 expert bow-string players were asked to 1) listen to a reference melody of four notes; 2) play that melody with a violin (Active Condition); and 3) listen passively to the replay of their performance (Replayed Condition). Randomly, the auditory feedback of one of the four melody notes was manipulated in the Active Condition by lowering or lifting the pitch by half semitone. We found that mistuned notes, independently of whether they were manipulated externally or were produced by natural playing errors, elicited an f-ERN followed by a P300. We also found that the amplitude of the f-ERN was larger for faster corrective movements than for slower ones. In addition, between the f-ERN and the P300, we also identified two negative components-one in parietal areas and another in central-right regions-whose amplitudes were greater for slower corrective movements. We suggest the existence of two error-monitoring systems: a "fast" system mediated by the medial frontal cortex that quickly corrects errors when certainty is high and a "slow" system mediated by the posterior parietal cortex that accumulates evidence under uncertainty before triggering correction., This work was partly sponsored by the Musical AI project (PID2019-111403GB-I00) funded by MCIN/AEI/ 10.13039/501100011033 and by 'ERDF A way of making Europe'; by the Project PID2021-128790NB-I00, funded by MCIN/AEI/ 10.13039/501100011033 / FEDER UE; and by the European Union Horizon 2020 research and innovation program under grant agreement No. 688269 (TELMI project). It has been additionally supported by the Excellence Research Group 2017SGR-974 funded by the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya and by the MDM-2017-0729-18-2M Maria de Maeztu Center of Excellence UBNeuro, funded by MCIN/AEI/ 10.13039/501100011033. ISM was supported by grant RYC-2013-12577, funded by MCIN/AEI/ 10.13039/501100011033 and by 'ESF Investing in your future'. Open access publication fees were partly covered by the University of Barcelona (Ajudes de la Universitat de Barcelona per a publicar en accés obert).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders

  • Ramírez, Sara
  • Haddad-Tóvolli, Roberta
  • Radosevic, Marija
  • Toledo, Miriam
  • Pané, Adriana|||0000-0002-7810-1827
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Ribas Ripoll, Vicent|||0000-0002-7266-6106
  • Milà-Guasch, Maria
  • Pozo, Macarena
  • Obri, Arnaud
  • Eyre Sánchez, Elena
  • Gómez-Valadés, Alicia G.
  • Chivite, Iñigo
  • Van Eeckhout, Tomas
  • Zalachoras, Ioannis
  • Altirriba, Jordi
  • Bauder, Corinna
  • Imbernón, Mónica
  • Garrabou, Glòria|||0000-0001-8973-9933
  • Garcia-Ruiz, Carmen
  • Nogueiras, Rubén|||0000-0002-9976-9930
  • Soto, David
  • Gasull, Xavier|||0000-0002-6154-8323
  • Sandi, Carmen|||0000-0001-7713-8321
  • Brüning, Jens C.
  • Fortea, Juan|||0000-0002-1340-638X
  • Jiménez Pineda, Amanda|||0000-0003-4967-1174
  • Fernández-Checa, José C.
  • Claret, Marc
Obesity and type 2 diabetes are associated with cognitive dysfunction. Because the hypothalamus is implicated in energy balance control and memory disorders, we hypothesized that specific neurons in this brain region are at the interface of metabolism and cognition. Acute obesogenic diet administration in mice impaired recognition memory due to defective production of the neurosteroid precursor pregnenolone in the hypothalamus. Genetic interference with pregnenolone synthesis by Star deletion in hypothalamic POMC, but not AgRP neurons, deteriorated recognition memory independently of metabolic disturbances. Our data suggest that pregnenolone's effects on cognitive function were mediated via an autocrine mechanism on POMC neurons, influencing hippocampal long-term potentiation. The relevance of central pregnenolone on cognition was also confirmed in metabolically unhealthy patients with obesity. Our data reveal an unsuspected role for POMC neuron-derived neurosteroids in cognition. These results provide the basis for a framework to investigate new facets of POMC neuron biology with implications for cognitive disorders. Ramírez et al. show that reduced hypothalamic pregnenolone levels, in the context of metabolic diseases, are associated with cognitive deterioration. POMC neuron-derived pregnenolone is a key mediator of cognition, but not metabolism, acting via hippocampal mechanisms. These results identify an unsuspected role for POMC neuron-derived pregnenolone in memory performance.